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Take home message: 
Using administrative data, we determined the extent to which hospital (rather than 




illness. Using highly granular patient data, we found that facilities with higher risk-and 
reliability-adjusted 30-day mortality had a higher probability of having patients under 






Purpose: Patients with persistent critical illness may account for up to half of all 
intensive care unit (ICU) bed-days. It is unknown if there is hospital variation in the 
development of persistent critical illness and if hospital performance affects the 
incidence of persistent critical illness. 
 
Methods: Retrospective analysis of Veterans admitted to the Veterans Administration 
(VA) ICUs from 2015–2017. Hospital performance was defined by the risk-and 
reliability-adjusted 30-day mortality. Persistent critical illness was defined as an ICU 
length of stay of at least 11 days. We used 2-level multilevel logistic regression models 
to assess variation in risk- and reliability-adjusted probabilities in the development of 
persistent critical illness.  
 
Results: In the analysis of 100 hospitals which encompassed 153,512 hospitalizations, 
4.9% (N=7,640/153,512) developed persistent critical illness. Furthermore, there was 
variation in the development of persistent critical illness despite controlling for patient 
characteristics (intraclass correlation: 0.067, 95% CI:0.049-0.091). Hospitals with higher 
risk-and reliability-adjusted 30-day mortality had higher probabilities of developing 
persistent critical illness (predicted probability: 0.057, 95% CI:0.051-0.063, p <0.01) 
compared to those with lower risk-and-reliability adjusted 30-day mortality (predicted 
probability: 0.046, 95% CI:0.041-0.051, p <0.01). The median odds ratio was 1.40 (95% 




two different VA hospitals, the patient admitted to the hospital with higher adjusted 
mortality, would have 40% greater odds of developing persistent critical illness. 
 
Conclusion: Hospitals with higher risk-and reliability- adjusted 30-day mortality have a 
higher probability of developing persistent critical illness. Understanding the drivers of 
this variation may identify modifiable factors contributing to the development of 
persistent critical illness. 
 






Patients with long continuous intensive care unit (ICU) stays have increased 
mortality and utilize a disproportionate number of ICU resources.1-5  Up to half of ICU 
bed-days may be occupied by patients who are or will become persistently critically ill.2,5  
The mechanisms leading patients to develop persistent critical illness are unclear. 
Recent work has focused on physiology and on understanding the cascade of organ 
failures, which occurs prior to the population onset of persistent critical illness.6-8   
However, patients’ physiologies evolve within hospitals and the type and quality 
of care differs among hospitals.9,10 It may be that patients who would previously die 
earlier during their ICU stay are now surviving their acute illness as a result of newly 
available superb care, only to remain in the ICU for prolonged periods of time resulting 
in persistent critical illness—a consequence of the ICU’s own success and “legacies of 
critical illness”.11 Conversely, it may be that low performing (e.g. unexpectedly high 
mortality) hospitals also have a higher number of patients with prolonged ICU stays 
because the patients were initially less optimally managed or more complications 
occurred during their care, which while not lethal, contributed to a prolonged ICU stay. 
The direction and magnitude of any association between ICU quality and the 
development of persistent critical illness is unknown, but would guide future research on 
what modifiable structural and process of care practices should be explored.12  
In this study, we sought to understand the variation in the development of 
persistent critical illness and the extent to which the variation in its development might 
be explained by hospital factors in a large health care system, the United States (US) 




those with lower risk-adjusted 30-day hospital mortality rates.13,14, Specifically, we 
aimed to test the hypothesis that, even after patient-level risk-and reliability-adjustment, 
there would be statistically significant and clinically meaningful variation in the 
development of persistent critical illness between hospitals. Moreover, we aimed to test 
the hypothesis that hospitals with higher risk-and reliability-adjusted 30-day mortality will 
have a higher probability of persistent critical illness as compared to hospitals with lower 






The US VA health system is one of the largest integrated health care delivery 
systems in the world with over 9 million beneficiaries and an electronic medical record 
which can be leveraged to capture daily data.15,16 
 
Study Population 
Data on Veterans in the VA health system were identified from the Veterans 
Affairs patient database (VAPD) 2015-2017 and represented over 100 hospitals.17 As 
has been previously described in a detailed methodological report, the VAPD includes 
extensive data and the information is structured at the patient-hospital-day and includes 
comorbidities, daily vital signs and labs, drug administrations, severity of illness on 
admission, admission categorizations and is linked to mortality.17  Analyses from the VA 
were approved by the IRB of the VA Ann Arbor Health System. 
We abstracted data from the VAPD of patients who were admitted to the ICU for 




population onset of persistent critical illness to occur at this time. The onset of persistent 
critical illness in these studies was defined when the in-hospital mortality was no better 
predicted by the acute admission physiology as compared to the patient’s 
comorbidities.2,5 Sensitivity analysis were performed at ICU day 6 and ICU day 16 in 
light of the heterogeneity of the development of persistent critical illness seen in 
different populations.2,5,18 
Patients were excluded if they were under the age of 18; documented to have a 
pre-existing neuromuscular disease (Supplemental Appendix A), which inherently 
would contribute to prolonged recoveries; were previously in a VA ICU in the preceding 
12 months in order to more reliably distinguish early and later time periods of critical 
illness; or if they had a pre-existing tracheostomy because of the association with the 
need for prolonged mechanical ventilation.1 Those with new tracheostomies were 
included if they remained in ICU. Hospitals were excluded if they had less than 25 ICU 
hospitalizations a year or had a less-equipped ICU (level 3 or 4 hospital complexity in 
VA nomenclature).  
 
The VA ICU Severity Score 
For internal risk-adjustment, the VA uses an illness severity measure (the VA 
ICU severity score), which is the predicted 30-day mortality based on several variables 
(age, admission diagnosis category, 29 comorbid conditions, and 11 laboratory values). 
We re-calculated the score using these same variables. Normal values were imputed 
when labs were not clinically measured as has been done in previous severity illness 




(Supplemental Appendix B)  This severity score performs similarly to APACHE IV, 
with a c-statistic of 0.874 in published work.13 
 
Statistical Analysis 
We present patient and hospitalization characteristics as counts (percentages), 
means (standard deviations (SDs)), or medians (interquartile ranges [IQR]) as 
appropriate. Elixhauser comorbidities were weighted and tabulated as described by 
using the weighted van Walraven method. 20  We used hospitalization as the unit of 
analysis, unless otherwise specified. We used two-sided significance testing and 
considered p <0.05 to be statistically significant. 
 
General Approach 
We first used 2-level multilevel logistic regression models to create a hospital 
performance measure—hospital risk- and reliability- adjusted 30-day mortality. We then 
used a 2-level multilevel logistic regression to assess variation in risk- and reliability-
adjusted probabilities in the development of persistent critical illness.21-24 We initially 
calculated the variation in the development of persistent critical illness across hospitals 
accounting for patient characteristics (demographics and risk factors). A subsequent 
model was built adjusting for hospital characteristics (complexity and teaching status). A 
final model was then built adjusting for the hospital risk-and reliability-adjusted 30-day 
mortality rates. All statistical code is already available at GitHub at 




analysis with Stata software 15.1 (StataCorp, College Station, TX) and SAS 9.4 (SAS 




We used reliability adjustment to avoid overestimating the probability of the 
development of persistent critical illness at hospitals with low case volume.25 To do this, 
we used a multilevel model with a random intercept for hospital. The three main 
advantages of using a random effects model are 1) to reduce the number of parameters 
estimated, 2) to adjust for hospital level covariates, and 3) to benefit from the property of 
shrinkage. The shrinkage estimator approach places more weight on a hospital’s point 
estimate when it is measured reliably but “shrinks” it toward the population mean when 
there is more error in the measurement (e.g. lower-case volume).21,23,26 We performed 
reliability adjustment by generating empirical Bayes estimates. 
 
Hospital Performance Measure: Hospital Risk-and Reliability- Adjusted 30-day Mortality 
To account for differences in case-mix, we created a hospital risk- and reliability- 
adjusted 30-day mortality variable. We used a multilevel logistic model in which the 
hospitalization was the first level and the hospital was the second level and the 
dependent variable was 30-day mortality.  At the hospitalization level, we adjusted for 
patient severity of illness (which includes age, admission diagnosis category, 29 
comorbid conditions, and 11 laboratory values on admission). The second level only 
included a hospital random effect. The random effect was then predicted using 




for each hospital). This was added back to the mean log (odds) of mortality and an 
inverse logit was performed to estimate the risk-and reliability-adjusted 30-day 
mortality.21,23 
A sensitivity analysis was performed utilizing a hospital risk- and reliability-
adjusted ICU mortality variable since persistent critical illness may be more related to 
ICU factors and not general hospital factors. (Supplemental Appendix C).   
 
Quantifying Variation after Risk-and Reliability-Adjustment for Persistent Critical Illness 
We created four multilevel logistic models. (Supplemental Appendix D lists all 
of the variables in each model.) For each model, we quantified the variation in the 
probability of developing persistent critical illness across hospitals using the intraclass 
correlation coefficient (ICC). We then directly compared the ICC for all three models 
(Model 1 was the empty model with no covariates, Model 2 included patient 
characteristics (age, gender, Elixhauser comorbidities, severity of illness on admission, 
diagnosis code on admission); Model 3 included the patient characteristics and hospital 
characteristics (hospital size, teaching status, complexity level and case-mix); Model 4 
included the patient and hospital characteristics and hospital risk- and reliability-
adjusted 30-day mortality) to understand how much variation was explained by the 
hospitals risk-and reliability-adjusted 30-day mortality. Predicted probabilities were 
calculated using post-estimation commands and were calculated from the final model 
(Model 4). The median odds ratio (MOR) was calculated from the final model as per the 
method of Merlo.24 We present MORs, as they provide more interpretable information 
on the odds ratio scale of the impact of hospitals on the development of persistent 




risk.24 The MOR quantifies the difference in the rates of persistent critical illness 
between hospitals.  A MOR of 1.0 implies that the odds of persistent critical illness are 
equivalent across hospitals; the larger the MOR, the more important the hospital-level 




We identified 4.9% hospitalizations (7,640 of the 153,512 ICU hospitalizations) in 
the VA from 2015 - 2017 that developed persistent critical illness with a range of 1 to 
251 persistent critical illness ICU hospitalizations per hospital. (Figure 1 and 
Supplemental Appendix Figure 1) The patients were predominately white men with a 
median age of 67 (IQR: 60, 73). (Table 1) The 100 hospitals were predominately level 1 
(highest) complexity and teaching hospitals. (Table 1) 
 
Hospital Risk-and Reliability-Adjustment 
 After risk-and reliability-adjustment for patient characteristics, there was 
significant variation between hospitals in the probability of the development of persistent 
critical illness (ICC: 0.067, 95% CI: 0.049 - 0.091). (Table 2) This implies 6.7% of the 
variance in the development of persistent critical illness is attributed to hospitals rather 
than differences in the patients who come to them. 
 Hospital characteristics (hospital size, teaching status, complexity level and case-
mix) explained nearly half the residual variation between hospitals in the probability of 
the development of persistent critical illness (ICC: 0.038, 95% CI: 0.027 - 0.053). In 
other words by adjusting for hospital characteristics, the variance attributed to hospitals 





Risk-And Reliability-Adjusted 30-day Mortality at the Hospital Level 
 Hospitals’ median risk-adjusted 30-day mortality was 0.039 (IQR: 0.035, 0.045). 
After accounting for the hospitals’ risk- and reliability- adjusted 30-day mortality, the 
residual variation between hospitals in the probability of the development of persistent 
critical illness was minimally reduced (ICC: 0.036 95% CI: 0.026 - 0.051). (Figure 2) 
Hospitals in the worst 20th percentile of risk-and reliability-adjusted 30-day hospital 
mortality were associated with a higher probability of persistent critical illness (predicted 
probability: 0.057, 95% CI: 0.051 - 0.063, p < 0.01) as compared to those in the best 
20th percentile (predicted probability: 0.046, 95% CI: 0.041 - 0.051, p < 0.01). The MOR 
for the development of persistent critical illness was 1.40 (95% CI: 1.33 - 1.49). In other 
words, for two patients with the same physiology on admission at two randomly chosen 
VA hospitals, the patient at the lower performing hospital would have, on average, 40% 




Hospitals continued to have significant variation in the probability of the 
development of persistent critical illness even after adjusting for patient characteristics 
on admission at alternate potential length-of-stay cut-off points: ICU day 6 (ICC: 0.051, 
95% CI: 0.038 - 0.067) and at ICU day 16 (ICC: 0.095, 95% CI: 0.067 - 0.132). 
(Supplemental Appendix C table C1 and C2) Hospital characteristics (hospital size, 




between hospitals in the probability of the development of persistent critical illness 
whether defined at cut-offs of ICU day 6 (ICC: 0.038, 95% CI: 0.029 - 0.051) or at ICU 
day 16 (ICC: 0.052, 95% CI: 0.036 - 0.074).  
After accounting for the risk- and reliability- adjusted 30-day mortality, the 
residual variation between hospitals in the development of persistent critical illness was 
further reduced when persistent critical illness was defined at the alternate cut-offs of 
ICU day 6 (ICC: 0.038, 95% CI: 0.028 - 0.050) and ICU day 16 (ICC: 0.046, 95% CI: 
0.032 - 0.066). When persistent critical illness was defined at alternative cut-offs, ICU 
day 6 or 16, the MOR was 1.41 (95% CI: 1.34 - 1.49) and 1.46 (95% CI: 1.37 - 1.59) 
respectively. 
When utilizing the hospitals’ risk-and reliability- adjusted ICU mortality as the 
quality metric, the residual variation between hospitals in the development of persistent 
critical illness was reduced (ICC: 0.026 95% CI: 0.018 - 0.037) and the MOR for the 




In this large retrospective national cohort of ICU hospitalizations in the VA, we 
determined the extent to which hospital (rather than patient) characteristics might 
explain variation in the development of persistent critical illness. There was clinically 
meaningful variation as evidenced in the MORs. Using highly granular patient data, after 




risk-and reliability-adjusted 30-day mortality had a higher probability of having patients 
under their care develop persistent critical illness. 
 
Relationship to Previous Studies 
Previous work in severe sepsis has found significant variation between hospitals 
in 30-day mortality.23,28,29 Additionally, prior studies have suggested that persistent 
critical illness may be driven by the development of late cardiovascular failure, 
specifically late sepsis.7  Similarly, variation in use of long-term acute care hospitals and 
tracheostomies have been noted.30-32 However, no previous studies have evaluated the 
extent to which hospital factors might contribute to the development of persistent critical 
illness, prolonged mechanical ventilation, or chronic critical illness.   
 
Study Implications 
The development of persistent critical illness is not reliably associated with 
currently identified patient factors.33 Neither patient age nor severity of illness on 
admission are consistently associated with the development of persistent critical illness, 
6,7,34 suggesting other factors may be contributing to the development of persistent 
critical illness. A patient’s acute pathophysiology is not only driven by the acute illness 
and premorbid conditions (e.g. frailty) but also by the care the patient receives.35,36  
This may imply that the development of persistent critical illness may share 
mechanisms with other forms of “failure to rescue”, including death.37,38 The 
mechanisms driving these findings may relate to implementation of bundles of care, 




not foster multidisciplinary communication. Each of these factors will need further 
exploration in future studies to understand the different pathways which result in the 
development of persistent critical illness. 
 
Strengths and Limitations 
Our study has several strengths. We examined a national health system with 
detailed daily physiologic data collected over a two-year period encompassing 153,512 
ICU hospitalizations and 100 hospitals. These data allowed us to risk- and reliability- 
adjust for 30-day mortality and patient factors. Second, we have shown the extent to 
which hospitals explain the variation in the development of persistent critical illness.  
There are also limitations to our study. First, we used ICUs within the VA 
healthcare system which may not be generalizable to other hospitals in the U.S. but 
may be generalizable to other national health care systems. For example, the 
prevalence of persistent critical illness in the VA is similar to the prevalence reported in 
Australia and New Zealand.2,5 However, the mortality in the VA ICU is significantly lower 
and many patients are discharged home unlike the patients in Australia and New 
Zealand.2 Second, we did not account for transfer to long term acute care hospitals 
which could potentially lead to lower rates of persistent critical illness. However, the VA 
does not generally transfer patients to such long-term acute care hospitals. In the VA, 
there were 828 patients who remained in the ICU for at least 30 days. Additionally, we 
cannot account for outside hospital ICU transfers to the VA ICUs. Third, while we have 
shown that hospitals impact the probability of developing persistent critical illness, we 




mortality. However, the investigation of such factors (e.g. surgical complications, referral 
to palliative care, nosocomial infections) can be operationalized and we aim to make it 
the subject to future studies. Fourth, we are not able to account for patients who have 
limitations of care (do not resuscitate or do not intubate orders) or who transition to 
comfort care while in the ICU, resulting in these hospitals having higher in-hospital 
mortality rates. Fifth, we were unable to account for ward capacity issues resulting in 
prolonged ICU stays and higher rates of persistent critical illness. Additionally, we did 
not account for other definitions of prolonged ICU stays such as the need for prolonged 
mechanical ventilation. However, we did use varying time points of an ICU length of 
stay to define persistent critical illness and found similar results. Lastly, while we 
focused on the hospital-level of variation in the development of persistent critical illness, 
clinician variation may also be a mechanism driving its development and will be the 
subject of future studies. 
 
Conclusion 
There is variation between hospitals in the development of persistent critical 
illness, which is, at least in part, explained by the quality performance of a given 
hospital, such that higher mortality hospitals have higher rates of persistent critical 
illness. Given these observations, research aimed at understanding what specific 
organizational characteristics reduce the likelihood of developing persistent critical 

















































































































Table 1: Demographics of the hospitalization from the VA from 2015-2017 
 







 N=153,512 N=145,872 N=7,640 
Age (years) median (IQR) 67 (60, 73) 67 (60, 72) 68 (62, 73) 
Race    
    White: N (%) 109,587 (71.4) 104,154 (71.4) 5,433 (71.1) 
    African American: N(%) 32,155 (21.0) 30,499 (20.9) 1,656 (21.7) 
    Other: N (%) 11,770 (7.6) 11,219 (7.7) 551 (7.2) 
Male: N (%) 146,548 (95.5) 139,153 (95.4) 7,395 (96.8) 
Elixhauser a:  median 
(IQR) 6 (1, 14) 6 (0, 13) 12 (5, 20) 
VA ICU severity score: 
median (IQR) 2.5 (1.0, 6.6) 2.4 (1.0, 6.2) 6.6 (2.7, 16.1) 
ICU length of stay (days): 
median (IQR) 3 (2, 5) 3 (2, 4) 15 (12, 20) 
Hospital length of stay: 
(days) median (IQR) 6 (4, 10) 6 (3, 9) 22 (16, 32) 
In-hospital mortality: N (%) 8,493 (5.5) 6,922 (4.7) 1,571 (20.6) 
Discharge Location    
  Home: N (%) 140,111 (91.2) 134,371 (92.1) 5,740 (75.1) 
  Facility: N (%) 5,132 (3.4) 4,794 (3.3) 338 (4.5) 
  Other/Unknown: N (%) 8,269 (5.4) 6,707 (4.6) 1,562 (20.4) 
HOSPITAL 
CHARACTERISTICS    
Hospital complexity level b    
   Level 1: N (%) 143,384 (93.4) 135,976 (93.2) 7,408 (97.0) 
   Level 2: N (%) 10,128 (6.6) 9,896 (6.8) 232 (3.0) 
Bed size: median (IQR) 159 (109, 244) 159 (109, 144) 167 (119, 248) 
ICU-case mix    
    Medical: N (%) 87860 (57.2) 83,262 (57.1) 4,598 (63.9) 
    Surgical: N (%) 55705 (36.2) 52,947 (36.3) 2,758 (36.1) 
    Other: N (%) 9947 (6.5) 9,663 (6.6) 284 (3.7) 
Teaching facility: N (%)  110,007 (71.7) 104,062 (71.4) 5,945 (77.8) 
Region    
  Midwest: N (%) 33,578 (21.9) 32,091 (22.0) 1,487 (19.5) 
  South: N (%) 71,404 (46.5) 67,701 (46.4) 3,703 (48.5) 
  West: N (%) 29,334 (19.1) 27,916 (19.1) 1,418 (18.5) 
  Northeast: N (%) 19,196 (12.5) 18,164 (12.5) 1,032 (13.5) 
a Weighted score of co-morbidities;  
b Within the VA, higher level ICUs (1 and 2) are associated with tertiary academic centers.  
ICU: intensive care unit 
IQR: interquartile range 






Table 2. Variance components of the multilevel logistic regression for the development 
of persistent critical illness. 
Model 1: empty model (intercept only) 
Variance at the hospital level (standard error) 0.213 (0.037) 
ICC of the hospital level (standard error) 0.061 (0.010) 
Model 2: patient characteristics (age, gender, comorbidities, severity of illness, admission 
diagnosis) 
Variance at the hospital level (standard error)    0.235 (0.040) 
ICC of the hospital level (standard error) 0.067 (0.011) 
Percent change in variance compared to Model 1 -9% 
Model 3: patient characteristics, hospital characteristics (complex level, teaching status, bed 
size, case-mix) 
Variance at the hospital level (standard error) 0.130 (0.023) 
ICC of the hospital level (standard error)                                          0.038 (0.006) 
Percent change in variance compared to Model 1 +31% 
Model 4: patient and hospital characteristics, hospital risk-and reliability-adjusted mortality 
Variance at the hospital level (standard error).                                    0.124 (0.022) 
ICC of the hospital level (standard error)                                           0.036 (0.006) 
Percent change in variance compared to Model 1      +48% 











1. Flow chart for hospitalizations 
 
2. Variation in the development of persistent critical illness. Hospitals are ranked 
by hospital risk-and-reliability adjusted 30-day mortality. Bars represent 95% confidence 
intervals. 
 
 
 
